Cancer Institute of New Jersey (CINJ), Lung Cancer/Thoracic Program

Fingerprint Dive into the research topics where Cancer Institute of New Jersey (CINJ), Lung Cancer/Thoracic Program is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Doxorubicin Medicine & Life Sciences
Carboplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Joseph Aisner

Joseph Aisner

Person

19742019
No photo of Jyoti Malhotra

Jyoti Malhotra

Person

20122019

Projects 2004 2015

Participation In The Eastern Cooperative Oncology Group

Aisner, J.

National Institutes of Health (NIH)

9/2/04 → 2/28/15

Project: Research project

Chemoprevention
Research Personnel
Clinical Trials
Guideline Adherence
Synthetic Vaccines

Research Output 1974 2019

A phase 1b, multicenter, open-label, dose-finding study of eribulin in combination with carboplatin in advanced solid tumors and non-small cell lung cancer

Goel, S., Swami, U., Kumar, K., Dittrich, C., Reyderman, L., Jain, M., Aisner, J., Song, J. & Petrylak, D. P., Sep 1 2019, In : Cancer chemotherapy and pharmacology. 84, 3, p. 567-578 12 p.

Research output: Contribution to journal › Article

eribulin
Carboplatin
Non-Small Cell Lung Carcinoma
Labels
Tumors

Association of Target Volume Margins With Locoregional Control and Acute Toxicities for Non-small cell lung cancer Treated With Concurrent Chemoradiation Therapy

Yegya-Raman, N., Reyhan, M., Kim, S., Deek, M. P., Yue, N., Zou, W., Malhotra, J., Aisner, J. & Jabbour, S., Jan 1 2019, In : Practical Radiation Oncology. 9, 1, p. e74-e82

Research output: Contribution to journal › Article

Non-Small Cell Lung Carcinoma
Tumor Burden
Radiotherapy
Radiation Pneumonitis
Therapeutics

Phase I neoadjuvant study of intravesical recombinant fowlpox-GM-CSF (rF-GM-CSF) or fowlpox-TRICOM (rF-TRICOM) in patients with bladder carcinoma

Portal, D. E., Weiss, R. E., Wojtowicz, M., Mansour, A., Monken, C., Mehnert, J., Aisner, J., Kane, M., Nishioka, J., Aisner, S., Peters, S., Stein, M., Kim, I., Mayer, T. M., Shih, W., Gulley, J., Streicher, H., Singer, E. A. & Lattime, E., Jan 1 2019, In : Cancer gene therapy.

Research output: Contribution to journal › Article

Fowlpox
Granulocyte-Macrophage Colony-Stimulating Factor
Urinary Bladder
Urinary Bladder Neoplasms
Carcinoma